However, the in vivo experiment from this study did not show any significant change of p53 expression in tumor tissues, either at the mRNA or protein level, illustrating that the mechanism of the antitumor effect of C3G in vitro and in vivo might be different. The gene discussed is TP53; the disease is neoplasm.